In Vitro & In Vivo Diagnostic Substances Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - In Vitro & In Vivo Diagnostic Substances
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P5+2+3+12+0
S35+1-0+1+0

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

DM
2017-08-15
QTNTQuotient LtdCowan D J Paul ESee RemarksS - Sale+OE$4.06-54,4603,430,715-2%-$221,111
2017-08-16
VNRXVolitionrx LtdRootsaert Rodney GerardSecretaryP - Purchase$2.77+3,6301,012,5460%+$10,055
2017-08-16
VNRXVolitionrx LtdReynolds Cameron JohnPres, CEOP - Purchase$2.77+3,6302,156,4670%+$10,055
DM
2017-08-14
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$155.00-58,0001,129,034-5%-$8,990,173
M
2017-08-14
LNTHLantheus Holdings, Inc.Avista Capital Partners Gp, LLC10%S - Sale$17.27-140,846240,092-37%-$2,432,665
M
2017-08-14
LNTHLantheus Holdings, Inc.Burgstahler David FDirS - Sale$17.27-140,846254,902-36%-$2,432,665
2017-08-15
OXFDOxford Immunotec Global PlcEdwardson PeterChief Operations OfficerS - Sale$16.14-9,73992,905-9%-$157,171
D
2017-08-09
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$154.54-17,0001,123,034-1%-$2,627,183
D
2017-08-08
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$68.68-4,00010,103-28%-$274,736
D
2017-08-08
NEOGNeogen CorpGreen Ronald DDirS - Sale+OE$68.49-4,3330-100%-$296,772
D
2017-08-08
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$155.22-18,0001,120,034-2%-$2,793,960
2017-08-07
OXFDOxford Immunotec Global PlcEdwardson PeterChief Operations OfficerS - Sale$17.70-22,371102,644-18%-$395,971
2017-08-03
IDXXIdexx Laboratories Inc /deKingsley Lawrence DDirP - Purchase$151.76+2,0003,344+149%+$303,517
M
2017-08-02
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.73+10,0003,181,6500%+$37,300
D
2017-07-28
QDELQuidel Corp /de/Steward Randall JCFOS - Sale+OE$34.09-94,21519,907-83%-$3,211,931
2017-07-28
QDELQuidel Corp /de/Abney Michael Donald Jr.SVP - DistributionS - Sale$33.83-1,173866-58%-$39,679
M
2017-07-28
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.72+15,0003,221,2000%+$55,800
DM
2017-07-27
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$33.83-36,000284,493-11%-$1,217,820
2017-07-27
NEOGNeogen CorpPapesh G BruceDirS - Sale$64.51-6,75019,696-26%-$435,443
2017-07-27
NEOGNeogen CorpTobin James PDirP - Purchase$64.64+5003,200+19%+$32,320
2017-07-27
ICCCImmucell Corp /de/Pessin Norman HSee Explanation of ResponsesP - Purchase$5.25+170,000650,000+35%+$892,500
2017-07-27
ICCCImmucell Corp /de/Pessin Brian L.See Explanation of ResponsesP - Purchase$5.25+30,00070,000+75%+$157,500
D
2017-07-20
QTNTQuotient LtdCowan D J Paul ESee Remarks, 10%S - Sale+OE$6.11-9,4203,485,1750%-$57,556
2017-07-19
NEOGNeogen CorpBradley EdwardVPS - Sale$66.33-5,00086,512-5%-$331,657
DM
2017-07-17
QTNTQuotient LtdCowan D J Paul ESee Remarks, 10%S - Sale+OE$6.39-90,5803,494,595-3%-$578,612
2017-07-14
ABIOArca Biopharma, Inc.Conway Robert EChairman of the BoardP - Purchase$2.49+10,00035,000+40%+$24,900
2017-07-12
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$18.05-10,000592,468-2%-$180,500
M
2017-07-07
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$16.24-150,0003,579,788-4%-$2,435,440
M
2017-07-07
NTLAIntellia Therapeutics, Inc.Atlas Venture Fund Ix, L.P.10%S - Sale$16.24-150,0003,579,788-4%-$2,435,440
D
2017-07-06
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale+OE$15.94-27,168461,668-6%-$433,006
M
2017-07-05
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$4.00+11,5003,503,5000%+$46,030
D
2017-07-05
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale+OE$16.58-32,832461,668-7%-$544,427
2017-06-29
NAVBNavidea Biopharmaceuticals, Inc.Regan William J.SVP, CCOP - Purchase$0.53+20,000172,977+13%+$10,586
DM
2017-06-28
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$27.30-36,000284,493-11%-$982,920
M
2017-06-27
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$4.09+8,5003,343,3500%+$34,795
D
2017-06-28
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale+OE$16.06-30,000461,668-6%-$481,797
M
2017-06-22
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.80+15,0003,780,8000%+$56,975
2017-06-20
LNTHLantheus Holdings, Inc.Avista Capital Partners Gp, LLC10%S - Sale$14.87-3,000,0001,762,208-63%-$44,610,000
2017-06-20
LNTHLantheus Holdings, Inc.Burgstahler David FDir, 10%S - Sale$14.87-3,000,0001,762,208-63%-$44,610,000
M
2017-06-19
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.77+15,0003,567,6000%+$56,574
2017-06-19
NEOGNeogen CorpBradley EdwardVPS - Sale$68.72-5,00091,512-5%-$343,577
2017-06-15
OXFDOxford Immunotec Global PlcKeiley Elizabeth MSVP, GCS - Sale$15.01-4,08525,393-14%-$61,305
D
2017-06-12
LNTHLantheus Holdings, Inc.Duffy Michael PSee RemarksS - Sale+OE$15.42-20,000168,234-11%-$308,400
2017-06-08
LNTHLantheus Holdings, Inc.Leno Sam RDirS - Sale$16.33-15,03340,266-27%-$245,489
2017-06-12
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$15.39-10,000602,468-2%-$153,900
2017-05-31
IDXXIdexx Laboratories Inc /deTwigge GiovaniCHROS - Sale$166.90-2,57216,332-14%-$429,272
D
2017-05-30
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$167.82-13,0001,117,994-1%-$2,181,643
AD
2017-05-10
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$162.69-27,0001,115,994-2%-$4,392,627
DM
2017-05-26
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$24.98-36,000284,493-11%-$899,160
2017-05-30
NAVBNavidea Biopharmaceuticals, Inc.Latkin JedCOO, CFOP - Purchase$0.44+7,60050,159+18%+$3,317
M
2017-05-26
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.81+54,5006,658,800+1%+$207,760
M
2017-05-19
NAVBNavidea Biopharmaceuticals, Inc.Latkin JedCOO, CFOP - Purchase$0.45+25,35942,559+147%+$11,426
2017-05-19
NEOGNeogen CorpBradley EdwardVPS - Sale$61.33-5,00096,512-5%-$306,659
2017-05-22
IDXXIdexx Laboratories Inc /deEnd William TDirS - Sale$162.55-5,00045,256-10%-$812,769
2017-05-17
VRMLVermillion, Inc.Palmieri Valerie BarberPres, CEOP - Purchase$1.80+55559,097+1%+$999
2017-05-12
LNTHLantheus Holdings, Inc.Schaffer Derace LDirS - Sale$16.55-5,00058,730-8%-$82,750
2017-05-15
OXFDOxford Immunotec Global PlcEdwardson PeterChief Operations OfficerS - Sale$14.66-10,000125,015-7%-$146,572
D
2017-05-12
NEOGNeogen CorpHerbert James LCOB, CEOS - Sale+OE$61.29-48,469882,212-5%-$2,970,544
D
2017-05-11
NEOGNeogen CorpHerbert James LCOB, CEOS - Sale+OE$62.01-8,107882,212-1%-$502,715
2017-05-10
LNTHLantheus Holdings, Inc.Schaffer Derace LDirS - Sale$15.75-10,00063,730-14%-$157,500
D
2017-05-10
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$162.69-27,0001,112,994-2%-$4,392,6270
D
2017-05-10
OXFDOxford Immunotec Global PlcSandberg Richard ADirS - Sale+OE$14.40-3,00017,174-15%-$43,2000
2017-05-09
LNTHLantheus Holdings, Inc.Avista Capital Partners Gp, LLC10%S - Sale$13.40-3,000,0002,602,208-54%-$40,200,000+4
2017-05-09
LNTHLantheus Holdings, Inc.Burgstahler David FDir, 10%S - Sale$13.40-3,000,0002,602,208-54%-$40,200,000+4
M
2017-05-08
OXFDOxford Immunotec Global PlcSchroeder Jeff R.Chief Commercial OfficerS - Sale$14.14-40,000127,147-24%-$565,6590
M
2017-05-08
OXFDOxford Immunotec Global PlcSchroeder Jeff R.Chief Commercial OfficerS - Sale$14.14-40,000127,147-24%-$565,6590
2017-05-09
LNTHLantheus Holdings, Inc.Schaffer Derace LDirS - Sale$14.75-10,00073,730-12%-$147,500-2
D
2017-05-05
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$160.61-26,0001,112,994-2%-$4,175,9380+1
D
2017-05-04
IDXXIdexx Laboratories Inc /deHenderson Rebecca MDirS - Sale+OE$159.95-1,70019,852-8%-$271,91200
DM
2017-05-01
QDELQuidel Corp /de/Bujarski Robert JosephSVP, Bus Dev, GCS - Sale+OE$24.27-43,22537,759-53%-$1,048,9480+3
2017-05-02
ABIOArca Biopharma, Inc.Mitchell Daniel JDirP - Purchase$2.71+11,00011,000New+$29,810-3-6
DM
2017-04-26
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$24.16-36,000284,493-11%-$869,640+1+2
D
2017-04-27
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$63.68-2,67610,103-21%-$170,402-2-1
2017-04-06
NEOGNeogen CorpBradley EdwardVPS - Sale$61.54-21,018101,512-17%-$1,293,4220-2+3
D
2017-04-03
OXFDOxford Immunotec Global PlcWrighton-Smith PeterCEOS - Sale+OE$15.43-30,000461,668-6%-$463,0050+1-7
2017-04-03
OXFDOxford Immunotec Global PlcSandberg Richard ADirS - Sale$15.47-3,00017,174-15%-$46,4200+1-7
2017-04-03
ABIOArca Biopharma, Inc.Selby Brian L.VP, FinanceS - Sale$2.46-1,1141,275-47%-$2,740+40+5
2017-04-04
ABIOArca Biopharma, Inc.Ozeroff Christopher DavidS.VP, GCS - Sale$2.41-41817,517-2%-$1,007+40+5
2017-04-04
ABIOArca Biopharma, Inc.Keuer Thomas ACOOS - Sale$2.41-39014,045-3%-$940+40+5
2017-04-04
ABIOArca Biopharma, Inc.Bristow Michael RPres, Chief Exec OfficS - Sale$2.41-72086,600-1%-$1,735+40+5
DM
2017-03-29
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$22.50-37,080284,493-12%-$834,204+10+8
2017-03-08
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$3.59+50,0003,317,950+2%+$179,508+12+18+48
2017-03-24
ABIOArca Biopharma, Inc.Conway Robert EDirP - Purchase$2.59+25,00025,000New+$64,750-1-1-3
D
2017-03-20
OXFDOxford Immunotec Global PlcKeiley Elizabeth MSVP, GCS - Sale+OE$16.05-3,00030,614-9%-$48,150000
2017-03-17
LNTHLantheus Holdings, Inc.Avista Capital Partners Gp, LLC10%S - Sale$12.20-3,000,0003,442,208-47%-$36,600,0000+30
2017-03-17
LNTHLantheus Holdings, Inc.Venkataraman SriramDir, 10%S - Sale$12.20-3,000,0003,442,208-47%-$36,600,0000+30
2017-03-17
LNTHLantheus Holdings, Inc.Burgstahler David FDir, 10%S - Sale$12.20-3,000,0003,442,208-47%-$36,600,0000+30
2017-03-15
LNTHLantheus Holdings, Inc.Healey Timothy GSVP, CommercialS - Sale$12.42-11,31483,112-12%-$140,555-1-4-9
M
2017-03-13
ICCCImmucell Corp /de/Tomsche David ScottDirP - Purchase$5.43+2,00072,789+3%+$10,861+2+4-1
M
2017-03-09
NTLAIntellia Therapeutics, Inc.Atlas Venture Associates Ix, L.P.10%S - Sale$13.91-21,1323,729,788-1%-$293,843+1+2-3
M
2017-03-09
NTLAIntellia Therapeutics, Inc.Formela Jean FrancoisDirS - Sale$13.91-21,1323,729,788-1%-$293,843+1+2-3
2017-02-28
IDXXIdexx Laboratories Inc /deHenderson Rebecca MDirS - Sale$145.19-6,50014,950-30%-$943,7210+2+6
AD
2016-08-25
IDXXIdexx Laboratories Inc /deHenderson Rebecca MDirS - Sale+OE$110.44-9,92421,450-32%-$1,095,9530+2+6
D
2017-03-03
OXFDOxford Immunotec Global PlcEdwardson PeterChief Operations OfficerS - Sale+OE$14.92-5,92348,271-11%-$88,38200+3
2017-03-01
IDXXIdexx Laboratories Inc /deKingsley Lawrence DDirP - Purchase$146.48+1,0001,135+741%+$146,480+1+1+6
D
2017-02-27
ABIOArca Biopharma, Inc.Selby Brian L.VP, FinanceS - Sale+OE$2.56-1612,389-6%-$4120-6+2
D
2017-02-28
ABIOArca Biopharma, Inc.Ozeroff Christopher DavidS.VP, GCS - Sale+OE$2.61-46517,935-3%-$1,2140-6+2
D
2017-02-28
ABIOArca Biopharma, Inc.Keuer Thomas ACOOS - Sale+OE$2.61-46514,435-3%-$1,2140-6+2
D
2017-02-28
ABIOArca Biopharma, Inc.Bristow Michael RPres, Chief Exec OfficS - Sale+OE$2.61-76387,320-1%-$1,9910-6+2
DM
2017-02-24
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$21.39-106,920280,306-28%-$2,287,314+5+5+5

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top